HIVR4P 2016

aidsmap news from HIVR4P 2016

• The ‘long tail’ problem: injected-PrEP trial will be extended due to persistence of drug in companion study

  PrEP
  Gus Cairns | 11 November 2016

  A study presented at last month’s HIV Research for Prevention (HIVR4P) conference in Chicago shows that in a minority of subjects who were given an experimental injectable drug as HIV pre-exposure prophylaxis ...

• Some of the Americans who need PrEP the most face the greatest barriers to getting it

  PrEP
  Roger Pebody | 25 October 2016

  The personal values and moral judgements of healthcare providers are likely to interfere with the appropriate provision of pre-exposure prophylaxis (PrEP), Sarah Calabrese of Yale University told the HIV Research for Prevention ...

• As PrEP knowledge increases in San Francisco, 12,500 people now thought to be on PrEP

  PrEP
  Liz Highleyman | 25 October 2016

  Knowledge about and use of HIV pre-exposure prophylaxis (PrEP) has greatly increased over the past few years in San Francisco, and surveillance estimates suggest that some 12,500 people are now on PrEP, ...

• New HIV prevention products will need marketing and effective health services to reach the people who need them

  HIV prevention policy
  Roger Pebody | 24 October 2016

  There is a naivety among many HIV prevention researchers and advocates about the steps needed to introduce and implement new HIV prevention technologies such as oral pre-exposure prophylaxis (PrEP), vaginal rings and ...

• Huge diversity in current HIV vaccine research, Research for Prevention conference hears

  The search for an HIV prevention vaccine
  Gus Cairns | 23 October 2016

  The HIV vaccine research field is currently going through probably its most fertile and diverse period yet, the second HIV Research for Prevention conference (HIVR4P) in Chicago heard last week. A high ...

• New microbicide enema achieves high levels of drug in rectal tissues in monkeys

  Microbicides
  Gus Cairns | 22 October 2016

  Rectal microbicides that protect against HIV transmission via anal sex are a bigger technical challenge than vaginal ones. The rectal lining is more delicate than the vaginal, so safety has been an issue; ...

• Rings, films or inserts? Researchers need to develop prevention products that make sense in women’s lives

  Microbicides
  Roger Pebody | 21 October 2016

  “We need to think outside of the box,” Sharon Hillier of the Microbicide Trials Network told the HIV Research for Prevention (HIVR4P 2016) conference in Chicago on Wednesday. Researchers should not be ...

• Vaginal and rectal bacteria may have a big influence on HIV transmission and microbicide efficacy

  The biology of HIV transmission
  Gus Cairns | 20 October 2016

  A number of presentations at the 2016 HIV Research for Prevention Conference (HIVR4P) in Chicago looked at the influence vaginal bacteria have on HIV susceptibility, and one presentation found that vaginal bacteria may ...

• Policy makers’ inaction is leading people to take PrEP ‘in the wild’

  PrEP
  Roger Pebody | 19 October 2016

  An increasing number of gay men and others at risk of HIV are seeking to protect their health with PrEP (pre-exposure prophylaxis), but the lack of PrEP provision and lack of regulatory ...

• Anal sex may transmit four in ten HIV infections in US women at high risk

  Sexual transmission
  Gus Cairns | 19 October 2016

  A study presented at the 2016 HIV Research for Prevention (HIVR4P) Conference in Chicago, USA suggests that, in women at high risk of HIV infection, 40% or more of the HIV infections in ...

• Second case report of PrEP failure due to drug-resistant virus

  PrEP
  Roger Pebody | 18 October 2016

  A PrEP user in New York City has become HIV positive with virus that is resistant to Truvada and other antiretroviral drugs, the HIV Research for Prevention (HIVR4P 2016) conference in Chicago ...